[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 893 Referred in House (RFH)]

  1st Session
                                 S. 893


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 26, 2005

 Referred to the Committee on Energy and Commerce, and in addition to 
    the Committee on the Judiciary, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 AN ACT


 
 To make technical corrections in the Anabolic Steroid Control Act of 
                                 2004.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TECHNICAL CORRECTIONS.

    Section 102(41)(A) of the Controlled Substances Act (21 U.S.C. 
802(41)(A)), as amended by the Anabolic Steroid Control Act of 2004 
(Public law 108-358), is amended by--
            (1) striking clause (xvii) and inserting the following:
            ``(xvii) 13b-ethyl-17b-hydroxygon-4-en-3-one;''; and
            (2) striking clause (xliv) and inserting the following:
            ``(xliv) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-
        eno[3,2-c]-pyrazole);''.

            Passed the Senate April 25, 2005.

            Attest:

                                             EMILY J. REYNOLDS,

                                                             Secretary.